Anti-HBc IgM antibodies are detectable at the outset of clinical disease; as the infection evolves, IgM anti-HBc levels gradually decline, often becoming undetectable within 6 months, and IgG class predominates, remaining for a long period (sometimes life-long) at detectable levels [15]. Here, KRT88P is linked to infection.